Titre : Cortex visuel

Cortex visuel : Questions médicales fréquentes

Termes MeSH sélectionnés :

Frailty
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cortex visuel : Questions médicales les plus fréquentes", "headline": "Cortex visuel : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cortex visuel : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-27", "dateModified": "2025-04-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cortex visuel" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cortex sensorimoteur", "url": "https://questionsmedicales.fr/mesh/D066191", "about": { "@type": "MedicalCondition", "name": "Cortex sensorimoteur", "code": { "@type": "MedicalCode", "code": "D066191", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.500.814" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cortex visuel primaire", "alternateName": "Primary Visual Cortex", "url": "https://questionsmedicales.fr/mesh/D000087642", "about": { "@type": "MedicalCondition", "name": "Cortex visuel primaire", "code": { "@type": "MedicalCode", "code": "D000087642", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.500.814.953.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Cortex visuel", "alternateName": "Visual Cortex", "code": { "@type": "MedicalCode", "code": "D014793", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Andreas S Tolias", "url": "https://questionsmedicales.fr/author/Andreas%20S%20Tolias", "affiliation": { "@type": "Organization", "name": "Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA; email: astolias@bcm.edu." } }, { "@type": "Person", "name": "Paul G Fahey", "url": "https://questionsmedicales.fr/author/Paul%20G%20Fahey", "affiliation": { "@type": "Organization", "name": "Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA; email: astolias@bcm.edu." } }, { "@type": "Person", "name": "Jacob Reimer", "url": "https://questionsmedicales.fr/author/Jacob%20Reimer", "affiliation": { "@type": "Organization", "name": "Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA; email: astolias@bcm.edu." } }, { "@type": "Person", "name": "Laura Baroncelli", "url": "https://questionsmedicales.fr/author/Laura%20Baroncelli", "affiliation": { "@type": "Organization", "name": "Institute of Neuroscience, National Research Council (CNR), I-56124 Pisa, Italy; Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, I-56128 Pisa, Italy. Electronic address: baroncelli@in.cnr.it." } }, { "@type": "Person", "name": "Alexander S Ecker", "url": "https://questionsmedicales.fr/author/Alexander%20S%20Ecker", "affiliation": { "@type": "Organization", "name": "Institute for Computer Science, University Göttingen, Göttingen, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Oral frailty: a concept analysis.", "datePublished": "2024-05-22", "url": "https://questionsmedicales.fr/article/38778380", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12903-024-04376-6" } }, { "@type": "ScholarlyArticle", "name": "Frailty and innovative participatory rehabilitation.", "datePublished": "2024-01-01", "url": "https://questionsmedicales.fr/article/38492946", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jnha.2023.100012" } }, { "@type": "ScholarlyArticle", "name": "Frailty and Polypharmacy in Primary Care.", "datePublished": "2023-05-26", "url": "https://questionsmedicales.fr/article/37231714", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/10998004231179485" } }, { "@type": "ScholarlyArticle", "name": "Frailty and outcomes in lacunar stroke.", "datePublished": "2022-12-14", "url": "https://questionsmedicales.fr/article/36525849", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jstrokecerebrovasdis.2022.106942" } }, { "@type": "ScholarlyArticle", "name": "Frailty: A Multidimensional Biopsychosocial Syndrome.", "datePublished": "2022-10-28", "url": "https://questionsmedicales.fr/article/36402498", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.mcna.2022.04.006" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Système nerveux", "item": "https://questionsmedicales.fr/mesh/D009420" }, { "@type": "ListItem", "position": 3, "name": "Système nerveux central", "item": "https://questionsmedicales.fr/mesh/D002490" }, { "@type": "ListItem", "position": 4, "name": "Encéphale", "item": "https://questionsmedicales.fr/mesh/D001921" }, { "@type": "ListItem", "position": 5, "name": "Prosencéphale", "item": "https://questionsmedicales.fr/mesh/D016548" }, { "@type": "ListItem", "position": 6, "name": "Télencéphale", "item": "https://questionsmedicales.fr/mesh/D013687" }, { "@type": "ListItem", "position": 7, "name": "Cerveau", "item": "https://questionsmedicales.fr/mesh/D054022" }, { "@type": "ListItem", "position": 8, "name": "Cortex cérébral", "item": "https://questionsmedicales.fr/mesh/D002540" }, { "@type": "ListItem", "position": 9, "name": "Cortex sensorimoteur", "item": "https://questionsmedicales.fr/mesh/D066191" }, { "@type": "ListItem", "position": 10, "name": "Cortex visuel", "item": "https://questionsmedicales.fr/mesh/D014793" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cortex visuel - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cortex visuel", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cortex visuel", "description": "Comment diagnostiquer une lésion du cortex visuel ?\nQuels tests évaluent la fonction visuelle ?\nQuels signes indiquent une dysfonction du cortex visuel ?\nQuel rôle joue l'électroencéphalogramme (EEG) ?\nComment évaluer la vision des couleurs ?", "url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Frailty&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cortex visuel", "description": "Quels sont les symptômes d'une lésion du cortex visuel ?\nComment se manifeste l'agnosie visuelle ?\nQu'est-ce que l'hémianopsie ?\nQuels troubles peuvent affecter la perception des mouvements ?\nQuels symptômes indiquent une migraine occulaire ?", "url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Frailty&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cortex visuel", "description": "Comment prévenir les lésions cérébrales ?\nQuels examens réguliers sont recommandés ?\nComment réduire le risque de migraines ?\nQuels conseils pour protéger la santé oculaire ?\nComment gérer le stress pour prévenir les troubles visuels ?", "url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Frailty&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cortex visuel", "description": "Quels traitements existent pour les troubles visuels ?\nComment traiter l'agnosie visuelle ?\nQuels médicaments peuvent aider les migraines visuelles ?\nComment la rééducation visuelle fonctionne-t-elle ?\nQuels sont les traitements pour l'hémianopsie ?", "url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Frailty&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cortex visuel", "description": "Quelles complications peuvent survenir après une lésion du cortex visuel ?\nComment l'hémianopsie affecte-t-elle la vie quotidienne ?\nQuels risques sont associés à l'agnosie visuelle ?\nQuelles sont les conséquences des migraines fréquentes ?\nComment les troubles visuels peuvent-ils affecter l'éducation ?", "url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Frailty&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cortex visuel", "description": "Quels facteurs augmentent le risque de lésions cérébrales ?\nComment l'âge influence-t-il les troubles visuels ?\nQuels rôles jouent les antécédents familiaux ?\nComment le diabète affecte-t-il la vision ?\nQuels comportements augmentent le risque de migraines ?", "url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Frailty&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une lésion du cortex visuel ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un examen neurologique et des imageries cérébrales comme l'IRM sont utilisés." } }, { "@type": "Question", "name": "Quels tests évaluent la fonction visuelle ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de champ visuel et d'acuité visuelle sont couramment utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une dysfonction du cortex visuel ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles de la perception visuelle, comme l'agnosie, peuvent indiquer une dysfonction." } }, { "@type": "Question", "name": "Quel rôle joue l'électroencéphalogramme (EEG) ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'EEG peut aider à détecter des anomalies électriques liées à des troubles visuels." } }, { "@type": "Question", "name": "Comment évaluer la vision des couleurs ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests spécifiques comme le test de Ishihara sont utilisés pour évaluer la vision des couleurs." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une lésion du cortex visuel ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles de la vision, des hallucinations visuelles et des difficultés de reconnaissance." } }, { "@type": "Question", "name": "Comment se manifeste l'agnosie visuelle ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "L'agnosie visuelle se manifeste par l'incapacité de reconnaître des objets malgré une vision intacte." } }, { "@type": "Question", "name": "Qu'est-ce que l'hémianopsie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "L'hémianopsie est une perte de vision dans une moitié du champ visuel, souvent due à des lésions cérébrales." } }, { "@type": "Question", "name": "Quels troubles peuvent affecter la perception des mouvements ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles comme la simultagnosie peuvent affecter la perception des mouvements et des objets." } }, { "@type": "Question", "name": "Quels symptômes indiquent une migraine occulaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles visuels temporaires, comme des éclairs lumineux ou des taches." } }, { "@type": "Question", "name": "Comment prévenir les lésions cérébrales ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les traumatismes crâniens, adopter un mode de vie sain et contrôler les maladies vasculaires." } }, { "@type": "Question", "name": "Quels examens réguliers sont recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des examens ophtalmologiques réguliers peuvent aider à détecter précocement des troubles visuels." } }, { "@type": "Question", "name": "Comment réduire le risque de migraines ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les déclencheurs connus, gérer le stress et maintenir une bonne hydratation peuvent aider." } }, { "@type": "Question", "name": "Quels conseils pour protéger la santé oculaire ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Porter des lunettes de soleil, éviter les écrans excessifs et avoir une alimentation équilibrée." } }, { "@type": "Question", "name": "Comment gérer le stress pour prévenir les troubles visuels ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques de relaxation comme le yoga et la méditation peuvent aider à réduire le stress." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles visuels ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la rééducation visuelle, la thérapie occupationnelle et parfois des médicaments." } }, { "@type": "Question", "name": "Comment traiter l'agnosie visuelle ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie cognitive et des exercices de reconnaissance peuvent aider à traiter l'agnosie." } }, { "@type": "Question", "name": "Quels médicaments peuvent aider les migraines visuelles ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les triptans et les anti-inflammatoires peuvent soulager les migraines." } }, { "@type": "Question", "name": "Comment la rééducation visuelle fonctionne-t-elle ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "La rééducation visuelle utilise des exercices pour améliorer la perception et la reconnaissance visuelle." } }, { "@type": "Question", "name": "Quels sont les traitements pour l'hémianopsie ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des stratégies de compensation et des exercices de champ visuel peuvent aider à gérer l'hémianopsie." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une lésion du cortex visuel ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles cognitifs, des problèmes de coordination et des difficultés d'apprentissage." } }, { "@type": "Question", "name": "Comment l'hémianopsie affecte-t-elle la vie quotidienne ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "L'hémianopsie peut compliquer la conduite, la lecture et d'autres activités nécessitant une vision complète." } }, { "@type": "Question", "name": "Quels risques sont associés à l'agnosie visuelle ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "L'agnosie peut entraîner des difficultés dans les interactions sociales et des problèmes d'autonomie." } }, { "@type": "Question", "name": "Quelles sont les conséquences des migraines fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des migraines fréquentes peuvent entraîner des troubles de l'humeur, de l'anxiété et des absences au travail." } }, { "@type": "Question", "name": "Comment les troubles visuels peuvent-ils affecter l'éducation ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les troubles visuels peuvent nuire à l'apprentissage, nécessitant des adaptations scolaires spécifiques." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de lésions cérébrales ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les traumatismes crâniens, les AVC et les maladies neurodégénératives augmentent le risque." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il les troubles visuels ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le vieillissement peut entraîner une dégénérescence des cellules nerveuses et des troubles visuels." } }, { "@type": "Question", "name": "Quels rôles jouent les antécédents familiaux ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux de troubles neurologiques peuvent augmenter le risque de dysfonction visuelle." } }, { "@type": "Question", "name": "Comment le diabète affecte-t-il la vision ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le diabète peut entraîner des complications oculaires comme la rétinopathie diabétique, affectant la vision." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque de migraines ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le stress, le manque de sommeil et une mauvaise alimentation peuvent déclencher des migraines." } } ] } ] }

Sources (4321 au total)

Oral frailty: a concept analysis.

Oral frailty has become a worldwide problem among older adults. Although researchers have conducted various studies on oral frailty, its definition remains controversial.... To clarify the concept of oral frailty.... Online databases PubMed, Web of Science, CINAHL, Cochrane Library, ProQuest, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), and Wanfang database w... The attributes of oral frailty were abnormal oral structure and/or decline in multi-faceted oral function and coexisting decline in physical, cognitive and social functions. Its antecedents were aging... Oral frailty could result in worse conditions among older adults physically, psychologically and socially. Tools based on the concept analysis need to be developed to comprehensively assess oral frail...

Frailty and Polypharmacy in Primary Care.

The Clinical Frailty Scale (CFS) is a clinical judgement-based frailty tool developed from the Canadian Study of Health and Aging. Many studies on the measurement of frailty and its effect on clinical... This cross-sectional study included 298 patients who were aged ≥65 years and admitted to Yenimahalle Family Health Center between May-2022 and July-2022. Frailty was evaluated by using CFS. Polypharma... There was a statistically significance between age groups, gender, smoking status, marital status, polypharmacy status, and FS (... Polypharmacy, especially excessive polypharmacy, may be a promising adjunct to frailty in identifying older patients whose health is more likely to worsen. Providers in primary care should also consid...

Frailty and outcomes in lacunar stroke.

Lacunar strokes (LS) are ischemic strokes of the small perforating arteries of deep gray and white matter of the brain. Frailty has been associated with greater mortality and attenuated response to tr... To analyze the association between frailty and outcomes in LS.... Patients with LS were selected from the National Inpatient Sample (NIS) 2016-2019 using the International Classification of Disease, 10... Of 48,980 patients with LS, 10,830 (22.1%) were severely frail. Severely frail patients were more likely to be older, have comorbidities, and pertain to lower socioeconomic status categories. Severely... Severe frailty in LS patients is associated with higher rates of complications and increased HRU. Risk stratification based on frailty may allow for individualized treatments to help mitigate adverse ...

Frailty and visual, auditory, olfactory, and taste senses in older patients visiting a frailty outpatient clinic.

Although studies have analyzed the relationship between frailty and human senses, few have comprehensively evaluated and examined their correlations. This study aimed to clarify the relationship betwe... The subjects were outpatients at the Locomo Frail Outpatient Clinic. Sensory organ items were evaluated subjectively, and frailty was classified as nonfrail or frail using the Kihon Checklist. Univari... A total of 269 and 226 participants were assigned to the nonfrail and frail groups, respectively. The frequency of sensory organ impairment was 10.1% for taste, 12.7% for smell, 44.6% for vision, and ... Olfactory impairment had the strongest correlation with frailty. Although the sense of smell decreases with disease and aging, olfactory impairment may be correlated with frailty as a symptom of neuro...

Prevalence of frailty and pre-frailty in patients with rheumatoid arthritis: a systematic literature review and meta-analysis.

Frailty is a common geriatric syndrome and is characterised by a decreased physiological reserve and increased vulnerability to stressors. Pre-frailty is a risk-state before frailty. A systematic lite... An SLR for the period 2001-2021 was undertaken. All studies (including conference abstracts) that reported on the prevalence of (pre)-frailty in patients with RA were included. Assessment of risk of b... 25/1,363 studies were included in the SLR. Weighted average age was 58.0 years. Pre-frailty prevalence rates ranged between 20.4%-71% (median: 35.8%); for frailty, rates between 1.2%-75.1% (median: 23... (Pre-)frailty is common in RA patients. Large part of the variation is explained by clinical and methodological heterogeneity. High-quality studies with validated frailty instruments specifically for ...

Self-Reported Frailty Screening Tools: Comparing Construct Validity of the Frailty Phenotype Questionnaire and FRAIL.

We examined the construct validity of 2 self-reported frailty questionnaires, the Frailty Phenotype Questionnaire (FPQ) and FRAIL, against the Cardiovascular Health Study frailty phenotype (CHS-FP).... Cross-sectional data analysis of longitudinal prospective cohort study.... We included data from 230 older adults (mean age: 67.2 ± 7.4 years) from the "Longitudinal Assessment of Biomarkers for characterization of early Sarcopenia and Osteosarcopenic Obesity in predicting f... We compared area under receiver operating characteristic curves (AUC), agreement, correlation, and predictive validity against outcome measures [Short Physical Performance Battery, 5 times repeat chai... Prevalence of prefrail/frail was 25.7%, 14.8%, and 48.3% for FPQ, FRAIL, and CHS-FP, respectively. Compared with FRAIL, FPQ had better diagnostic performance (AUC = 0.617 vs 0.531, P = .002; sensitivi... Our results support complementary validity of FPQ and FRAIL in independent community-dwelling older adults. FPQ has increased case detection sensitivity with good predictive validity, whereas FRAIL de...

Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver Cirrhosis.

Frailty is common in patients with cirrhosis and increases the vulnerability to internal and external stressors. This study aimed to investigate the impact of frailty, as defined by the Clinical Frail... We analyzed data of 201 nonelectively hospitalized patients with cirrhosis and without higher-grade chronic kidney disease. Patient characteristics were captured within the first 24 hours of hospital ... In the total cohort, median CFS was 3 (interquartile range 3-4), and 34 (16.9%) patients were frail (CFS >4). During the hospital stay, 110 (54.7%) and 49 (24.3%) patients developed AKI or HRS-AKI, re... Frailty in patients with cirrhosis is associated with AKI and HRS-AKI. In this context, CFS appears to be a reliable tool to identify patients at high risk for developing AKI or HRS-AKI on hospital ad...

Frailty under COVID-19 pandemic in Japan: Changes in prevalence of frailty from 2017 to 2021.

After the outbreak of the coronavirus disease 2019 (COVID-19), "pandemic-associated-frailty" or profound health deterioration, in older adults has been considered a health concern. In this study, we s... A total of 5222 older adults in Otawara City, Tochigi Prefecture, aged 70 and 75 were surveyed annually using a complete survey, excluding those who were certified as requiring long-term care. Frailty... The frailty statuses over the five-year period showed a significant decrease in Robust and a significant increase in Pre-frailty and Frailty (p < 0.001). Frailty increased markedly during the second y... The population prevalence of frailty in older adults increased steadily from the pre-pandemic year through the first and second years of the pandemic. Based on the 25 questions of the KCL, two aspects...